FDA Inspection 1222593 — B. Braun US Pharmaceutical Manufacturing, LLC

B. Braun US Pharmaceutical Manufacturing, LLC — FEI 2021236

The FDA completed an inspection of B. Braun US Pharmaceutical Manufacturing, LLC on October 13, 2023 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 13, 2023
Fiscal Year
2024
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Irvine, CA (United States)